# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Mar 31, 2017

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2017-03-31
- Accepted by EDGAR: Mar 31, 2017, 16:10 ET
- Period: not reported
- Accession: 0001493152-17-003215
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315217003215/sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315217003215/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315217003215/sc13da.htm

Filed Mar 31, 2017.
Source: SEC EDGAR, the filing index for accession 0001493152-17-003215. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.